Author:
Yu-Shan Chen
Yu-Shan Chen
Department of Business Administration, National Taipei University, 151, University Rd., San Shia, Taipei 237, Taiwan
Search for other papers by Yu-Shan Chen in
Current site
Google Scholar
PubMed
Search for other papers by Yu-Shan Chen in
Current site
Google Scholar
PubMed
Abstract
This study applies patent analysis to discuss the influences of the three aspects of patent trait—a firm's revealed technology advantage in its most important technological field (RTAMIT), relative patent position in its most important technological field (RPPMIT), and patent share in its most important technological field (PSMIT)—upon corporate growth and discusses the moderation effect of relative growth rate of its most important technological field (RGRMIT) in the American pharmaceutical industry. The results demonstrate that the three relationships between corporate growth and the three aspects of patent trait are positive, and verify that RGRMIT moderates the three relationships. This study suggests that pharmaceutical companies should enhance their R&D capabilities, the degree of leading position, and concentration of R&D investment in their most important technological fields to increase their growth. Finally, this study classifies the pharmaceutical companies into four types, and provides some suggestions to them.
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
Barney, J 1991 Firm resources and sustained competitive advantage. Journal of Management 17 1 99–120 .
-
Barney, J, Hesterly, W 2009 Strategic management and competitive advantage: Concepts and cases Prentice Hall Publisher Upper Saddle River, NJ.
-
Branch, B 1973 Research and development and its relation to sales growth. Journal of Economics and Business 25 2 107–111.
-
Breitzman, A, Thomas, P 2002 Using patent citation analysis to target/value M&A candidates. Research Technology Management 45 5 28–36.
-
Brockhoff, K 1991 Competitor technology intelligence in German companies. Industrial Marketing Management 20:91–98 .
-
Cardinal, LB, Hatfield, DE 2000 Internal knowledge generation: The research laboratory and innovative productivity in the pharmaceutical industry. Journal of Engineering & Technology Management 17:247–271 .
-
Chen, Y-S, Chang, K-C 2009 Using neural network to analyze the influence of the patent performance upon the market value of the US pharmaceutical companies. Scientometrics 80 3 637–655 .
-
Chen, Y-S, Chang, K-C 2010 The relationship between a firm's patent quality and its market value—the case of US pharmaceutical industry. Technological Forecasting and Social Change 77 1 20–33 .
-
Chen, Y-S, Chang, K-C 2010 Exploring the nonlinear effects of patent citations, patent share, and relative patent position on market value in the US pharmaceutical industry. Technology Analysis & Strategic Management 22 2 153–169 .
-
Chen, Y-S, Chang, K-C 2010 The nonlinear nature of the relationships between the patent traits and corporate performance. Scientometrics 82 1 201–210 .
-
Chen, Y-S, Chang, K-C 2010 Analyzing the nonlinear effects of firm size, profitability, and employee productivity on patent citations of the US pharmaceutical companies by using artificial neural network. Scientometrics 82 1 75–82 .
-
Chen, Y-S, Lin, M-JJ, Chang, C-H 2006 The influence of intellectual capital on new product development performance—the manufacturing companies of Taiwan as an example. Total Quality Management and Business Excellence 17 10 1323–1339 .
-
Deng, Z, Lev, B, Narin, F 1999 Science and technology as predictors of stock performance. Financial Analysts Journal 55:20–32 .
-
Ernst, H 1995 Patenting strategies in the German mechanical engineering industry and their relationship to company performance. Technovation 15 4 225–240 .
-
Ernst, H 1998 Patent portfolios for strategic R&D planning. Journal of Engineering and Technology Management 15:279–308 .
-
Ernst, H 1999 Evaluation of dynamic technological developments by means of patent data K Brockhoff AK Chakrabarti J Hauschildt eds. The dynamics of innovation: Strategic and managerial implications Springer Corp Berlin.
-
Ernst, H 2001 Patent applications and subsequent changes of performance: Evidence from time-series cross-section analyses on the firm level. Research Policy 30:143–157 .
-
Ernst, H 2003 Patent information for strategic technology management. World Patent Information 25:233–242 .
-
Feeny, S, Rogers, M 2003 Innovation and performance: Benchmarking Australian firms. Australian Economic Review 36 3 253–264 .
-
Gebhart, F 2006 Major drugs lose patent protection in 2006. Drug Topics Supplements 150:8–10.
-
Grabowski, H, Vernon, J 1990 A new look at the returns and risks to pharmaceutical R&D. Management Science 36:804–821 .
-
Granstrand, O, Patel, P, Pavitt, K 1997 Multitechnology corporations: Why they have distributed rather than distinctive core competencies. California Management Review 39 4 8–25.
-
Greene, WH 2003 Econometric analysis Prentice-Hall Publisher Upper Saddle River, NJ.
-
Hall, BH, Jaffe, A, Trajtenberg, M 2005 Market value and patent citations. Rand Journal of Economics 36 1 16–38.
-
Henry, G 2002 Patents, innovation, and access to new pharmaceuticals. Journal of International Economic Law 5 4 849–860 .
-
Hoy, F, McDougall, PP, Dsouza, DE 1992 Strategies and environments of high growth firms DL Sexton JD Kasarda eds. The state of the art of entrepreneurship PWS-Kent Publishing Boston.
-
Hsiao, C 1986 Analysis of panel data Cambridge University Press Cambridge, UK.
-
IMS Health 2010 Global pharmaceutical market growth of 5–7 percent in 2011 IMS Health Norwalk, CT.
-
Jensen, E 1987 Research expenditures and the discovery of new drugs. Journal of Industrial Economics 36:83–95 .
-
Johnson, WHA 1999 An integrative taxonomy of intellectual capital: Measuring the stock and flow of intellectual capital components in the firm. International Journal of Technology Management 18 5–8 562–575 .
-
Lee, YG, Lee, JD, Song, YI, Lee, SJ 2007 An in-depth empirical analysis of patent citation counts using zero-inflated count data model: The case of KIST. Scientometrics 70 1 27–39 .
-
Levin, RC, Klevorick, AK, Nelson, RR, Winter, SG 1987 Appropriating the returns from industrial research and development. Bookings Paper on Economic Activity 3:783–820 .
-
Lin, B, Chen, J 2005 Corporate technology portfolios and R&D performance measures: A study of technology intensive firms. R&D Management 35 2 157–170 .
-
Maddala, GS 1993 The econometrics of panel data Elgar Publisher Aldershot.
-
Mansfield, E 1986 Patents and innovation: An empirical study. Management Science 32:173–181 .
-
Miller, SM 1990 The strategic management of technological R&D: An ideal process for the 1990s. International Journal of Technology Management 5 2 153–163.
-
Patel, P, Pavitt, K 1997 The technological competency of the world's largest firms: Complex path-dependent, but not much variety. Research Policy 26:141–156 .
-
Pearson, AE 2002 Tough-minded ways to get innovative. Harvard Business Review 80 8 117–125.
-
Prahalad, CK, Hamel, G 1990 The core competence of the corporation. Harvard Business Review 68:79–91.
-
Rosenberg, JB 1976 Research and market share: A reappraisal of the Schumpeter hypothesis. Journal of Industrial Economics 25 2 101–111 .
-
Scherer, FM 1965 Corporate inventive output, profits, and growth. Journal of Political Economy 73 3 190–197 .
-
Schmookler, J 1966 Invention and economic growth Harvard University Press Boston.
-
Soete, L, Wyatt, S 1983 The use of foreign patenting as an internationally comparable science and technology output indicator. Scientometrics 5 1 31–54 .
-
Teece, DJ 1986 Profiting from technological innovation: Implications for integration, collaboration, licensing and public policy. Research Policy 15 6 285–305 .
-
Urabe, K 1988 Innovation and management: International comparisons Walter de Gruyter & Co New York.
-
U.S. Bureau of Economic Analysis 2010 Industry economic accounts U.S. Bureau of Economic Analysis Washington, DC.
-
Zahra, SA, Bogner, WC 1999 Technology strategy and software new ventures’ performance: Exploring the moderating effect of the competitive environment. Journal of Business Venturing 15 2 135–173 .
To see the editorial board, please visit the website of Springer Nature.
Manuscript submission: http://www.editorialmanager.com/scim/
For subscription options, please visit the website of Springer Nature.
| Scientometrics | |
|---|---|
| Language | English |
| Size | B5 |
| Year of Foundation |
1978 |
| Volumes per Year |
1 |
| Issues per Year |
12 |
| Founder | Akadémiai Kiadó |
| Founder's Address |
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245. |
| Publisher | Akadémiai Kiadó Springer Nature Switzerland AG |
| Publisher's Address |
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245. CH-6330 Cham, Switzerland Gewerbestrasse 11. |
| Responsible Publisher |
Chief Executive Officer, Akadémiai Kiadó |
| ISSN | 0138-9130 (Print) |
| ISSN | 1588-2861 (Online) |
Monthly Content Usage
| Abstract Views | Full Text Views | PDF Downloads | |
|---|---|---|---|
| Jun 2024 | 25 | 6 | 2 |
| Jul 2024 | 28 | 1 | 1 |
| Aug 2024 | 34 | 0 | 0 |
| Sep 2024 | 37 | 1 | 1 |
| Oct 2024 | 176 | 0 | 0 |
| Nov 2024 | 44 | 0 | 0 |
| Dec 2024 | 4 | 0 | 0 |
Author:
Author:
Copyright Akadémiai Kiadó AKJournals is the trademark of Akadémiai Kiadó's journal publishing business branch.
Powered by PubFactory